Antimicrobial Use among Adult Inpatients in Northern Canada, 2019–2021
This study represents the largest collection of antimicrobial use data for inpatients in northern Canada to date. From 2019 to 2021, there was an increase in antimicrobial use of 195 DDD/1000pd, largely driven by increases in the use of third- and first-generation cephalosporins. The findings should be interpreted with caution, as results may not be generalizable to all northern hospitals.
Authors
- Jacquie Jenkins (ORCID: https://orcid.org/0000-0002-4337-8543)
- Linda Pelude
- Joëlle Cayen
- Jessica Bartoszko (ORCID: https://orcid.org/0000-0001-6743-3538)
- Edith Lee
- Darren Pasay (ORCID: https://orcid.org/0000-0001-8956-6032)
- Wallis Rudnick (ORCID: https://orcid.org/0000-0003-3457-4216)
- Daniel J. G. Thirion (ORCID: https://orcid.org/0000-0002-2474-2186)
- John Maynard Conly (ORCID: https://orcid.org/0000-0002-3348-0157)
- Jean Bélanger
- Siebe D. Bos
- Alicia Rahier
- Chris Bessey
- Ginette Dutrisac
Institutions
- Alberta Health Services (CA)
- University of Northern British Columbia (CA)
- Public Health Agency of Canada (CA)
- McGill University Health Centre (CA)
- Foothills Medical Centre (CA)
- Health Sciences North (CA)
- Nunavut Research Institute (CA)
- Government of Northwest Territories (CA)
- McGill University (CA)
Publication Details
- Journal
- The Canadian Journal of Hospital Pharmacy
- Published
- 2024-12-11
- DOI
- https://doi.org/10.4212/cjhp.3595
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- World Health Organization
- Public Health Agency of Canada
- Public Health Agency
- Canadian Institutes of Health Research